PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-90.13%
Negative revenue growth is a classic Benjamin Graham warning sign. While possibly cyclical, verify Market Share trends and Competitive Position.
No Data
No Data available this quarter, please select a different quarter.
-148.93%
Negative gross profit growth is a serious warning sign. Benjamin Graham would demand thorough analysis of pricing power and cost structure.
-595.65%
Negative gross margin growth suggests serious pricing or cost issues. Benjamin Graham would demand thorough analysis.
15.04%
R&D growth above 10% signals aggressive investment. Seth Klarman would demand evidence of future payoff potential.
33.15%
G&A growth above 5% signals concerning overhead expansion. Seth Klarman would demand justification for increased costs.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.43%
Operating expenses growth above 10% signals concerning cost expansion. Seth Klarman would demand justification.
20.43%
Total costs growth above 5% signals concerning expansion. Seth Klarman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
3.01%
D&A growth 0-5% reflects moderate asset expansion. Benjamin Graham would check if growth drives future value.
-24.86%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
-1164.87%
Negative EBITDA margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
-24.41%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-1160.31%
Negative operating margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
-17.39%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
-24.71%
Negative pre-tax income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-1163.35%
Negative pre-tax margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-24.71%
Negative net income growth needs thorough analysis. Benjamin Graham would examine operational issues.
-1163.35%
Negative net margin growth needs thorough analysis. Benjamin Graham would examine operational issues.
-23.33%
Negative EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
-23.33%
Negative diluted EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.